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At present, acutely symptomatic nonruptured AAAs
are differentiated from ruptured AAAs primarily on the
basis of history and examination, but even the most expe-
rienced of vascular surgeons cannot always confidently
exclude rupture with clinical assessment alone.5 Many clin-
icians have advocated the use of emergency computed
tomographic (CT) scanning in this situation, but previous
results from this group have shown that, in cases of true
clinical uncertainty, CT scan has an unacceptably low sen-
sitivity and specificity.6 Previous results from this group
have also shown that ruptured AAA is associated with
intense thrombin generation and inhibition of systemic fib-
rinolysis.7 To date, there are no reports of hemostatic func-
tion in patients with acutely symptomatic nonruptured
AAA. We hypothesised that, because acutely sympto-
matic nonruptured AAA is not associated with extramural
hemorrhage, this group of patients would not manifest the
same pattern of hemostatic derangement as patients with
rupture. As such, hemostatic variables might aid clinical
decision-making regarding the timing of surgery in
patients with acutely symptomatic nonruptured AAA. The
aims of this study were two-fold. The first aim was the
examination of whether patients who undergo repair of
acutely symptomatic nonruptured AAA exhibited the same
hemostatic derangement as those who underwent opera-
In the United Kingdom, more than 50% of all abdom-
inal aortic aneurysm (AAA) repairs are performed on an
emergency basis because the surgeon believes, or is unable
to exclude the possibility, that rupture has occurred.
However, in approximately 20% of these patients, the AAA
is found to be intact, and sudden expansion or impending
rupture are presumed to be responsible for the patient’s
symptoms.1 The operative mortality rate for this group of
patients is twice that of symptomatic patients in whom
rupture is not suspected and who do not undergo opera-
tion on an emergency basis.1-4
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Background: In patients with acutely symptomatic but nonruptured abdominal aortic aneurysm (AAA), emergent repair
is associated with an increased mortality rate as compared with semi-elective repair. Previous results have shown that
ruptured but not asymptomatic AAA repair is associated with intense thrombin generation and inhibition of systemic
fibrinolysis. The purpose of this study was to determine whether circulating markers of coagulation and fibrinolysis
may be used to distinguish acutely symptomatic nonruptured and ruptured AAA.
Methods: A prospective study was performed of 44 patients who underwent emergency AAA repair for suspected rup-
ture. Platelet count, fibrinogen level, prothrombin time, activated partial thromboplastin time, tissue plasminogen acti-
vator (t-PA) activity, plasminogen activator inhibitor (PAI) activity, prothrombin fragment (PF) 1+2 level, and D dimer
level were measured before surgery.
Results: When compared with ruptured AAAs (n = 37), acutely symptomatic nonruptured AAAs (n = 7) were associ-
ated with increased fibrinogen level (P = .033), reduced activated partial thromboplastin time (P = .043), increased t-
PA activity (P = .023), reduced PAI activity (P = .005), reduced PF 1+2 level (P = .001), and reduced D dimer level (P
= .005; all P values determined with Mann-Whitney test). The differences in t-PA activity (P = .01), PAI activity (P =
.004), and PF 1+2 level (P = .01) persisted in patients whose conditions were normotensive. In all patients, a PF 1+2
level of greater than or equal to 2.5 nmol/L was associated with a sensitivity, specificity, and positive and negative pre-
dictive value for rupture of 89%, 86%, 97%, and 60%, respectively. In patients whose conditions were normotensive, PAI
activity of greater than or equal to 16 AU/mL was associated with a sensitivity, specificity, and positive and negative
predictive value of 83%, 100%, 100%, and 88%, respectively.
Conclusion: These data show that acutely symptomatic nonruptured AAA is associated with increased systemic fibri-
nolysis (caused by reduced fibrinolytic inhibition) and reduced thrombin generation as compared with rupture.
Preoperative hemostatic markers, particularly PF 1+2 level and PAI activity, may distinguish acutely symptomatic non-
ruptured from ruptured AAA. (J Vasc Surg 2002;35:661-5)
tion for rupture. The second aim was the determination of
the feasibility of hemostatic markers as diagnostic adjuncts.
METHODS
Patients. Forty-four patients who underwent emer-
gency operation for suspected rupture of infrarenal AAA
were prospectively studied. At operation, 37 patients (33
men and four women; median age, 74 years; range, 63 to
87 years) were found to have ruptured AAAs and seven
men (median age, 68 years; range, 65 to 74 years) had
nonruptured AAAs. Thirty-one patients with rupture had
at least one documented episode of hypotension (systolic
blood pressure, <100 mm Hg) before surgery. Seven
patients with acutely symptomatic nonruptured AAAs and
six patients with rupture were not hypotensive before
surgery. The clinical data for both groups of patients are
shown in Table I. Rupture was defined by the presence of
fresh retroperitoneal or intraperitoneal blood in the pres-
ence of an aortic aneurysm with no other identifiable
cause for the findings. In patients with acutely sympto-
matic nonruptured AAAs, sudden expansion or impending
rupture were presumed to be responsible for the clinical
findings because there were no other identifiable causes.
Sample collection. Blood was sampled from an
indwelling arterial line immediately before the induction
of anesthesia. No patients underwent a blood transfusion
before blood sampling. The samples were placed immedi-
ately on ice and centrifuged within 30 minutes of collec-
tion at 3000 revolutions per minute for 30 minutes at 4°C
(equivalent to 1400g). Plasma was separated and stored at
–70°C for later batch analysis.
Markers of thrombin generation and fibrinolysis.
Platelet count, fibrinogen level, prothrombin time (PT),
and activated partial thromboplastin time (aPTT) were
measured in the routine hematology laboratory. Plasma
prothrombin fragment (PF) 1+2 (healthy range, 0.4 to
1.1 nmol/L) was assayed as a marker of thrombin gener-
ation. Plasma tissue plasminogen activator (t-PA) activity
(healthy range, 0.2 to 2.0 IU/mL) and plasminogen acti-
vator inhibitor (PAI) activity (healthy range, <15
AU/mL) were assayed as markers of primary systemic fi-
brinolysis. D dimer (healthy range, 630 to 850 ng/mL)
was assayed as a marker of secondary fibrinolysis. The
healthy range for each hemostatic marker was determined
by the manufacturer of the assay. Details of the commer-
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Table I. Clinical data for patients with acutely sympto-
matic nonruptured and ruptured abdominal aortic
aneurysm
Ruptured Nonruptured  
AAA AAA 
(n = 37) (n = 7)
Median age (y) 74 (range, 68 (range, 
63 – 87) 65 – 74)
Gender 33 M, 4 F 7 M
Hypotension (systolic BP, 31 –
<100 mm Hg)
Comorbidity
None 6 3
Myocardial infarction 13 –
Angina pectoris 10 1
Coronary artery bypass graft – 1
Hypertension 13 2
Congestive cardiac failure 2 –
Atrial fibrillation 2 –
Stroke 4 –
Peripheral arterial occlusive disease 2 –
Venous thromboembolism – 1
Chronic obstructive airways disease 6 –
Non–insulin-dependent diabetes 1 –
mellitus
Cigarette smoking
Nonsmoker 17 3
Ex-smoker 2 1
Current smoker 12 3
Medications
None 6 4
Aspirin 15 1
Diuretic 12 2
Nitrate 10 1
Angiotensin-converting enzyme 6 1
inhibitor
Calcium-channel blocker 4 1
Beta-adrenoceptor blocker 1 1
Bronchodilator 6 –
AAA, Abdominal aortic aneurysm; M, male; F, female; BP, blood pressure.
Fig 1. Preoperative tissue plasminogen activator activity in
acutely symptomatic and ruptured abdominal aortic aneurysm.
Upper and lower limits of healthy range are shown with horizon-
tal lines.
Fig 2. Preoperative plasminogen activator inhibitor activity in
acutely symptomatic and ruptured abdominal aortic aneurysm.
Upper limit of healthy range is shown with horizontal line.
cially available assays of coagulation and fibrinolysis have
been described in a previous report.7
Statistical methods. The Mann-Whitney test was
used for the comparison of groups of patients. A probabil-
ity value of less than .05 was regarded as statistically sig-
nificant. The sensitivity, specificity, and positive and
negative predictive values of each assay (alone and in com-
bination) for the diagnosis of ruptured AAA as compared
with operative findings were determined.
RESULTS
Clinical data. There were no deaths after repair of
acutely symptomatic nonruptured AAA. The inhospital
mortality rate for repair of ruptured AAA was 16 of 37
patients (43%): seven patients died during surgery or
within 24 hours of repair, and nine patients died in the late
postoperative period. There were no deaths among the six
patients with ruptured AAAs whose conditions were nor-
motensive before surgery.
Markers of fibrinolysis and thrombin generation.
The median and range values for preoperative platelet
count, fibrinogen level, PT, and aPTT are shown in Table
II. The median and range values for preoperative t-PA
activity, PAI activity, PF 1+2, and D dimer levels are
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shown in Table III. When compared with ruptured AAA,
acutely symptomatic nonruptured AAA was associated
with significantly higher fibrinogen level (P = .033),
reduced aPTT (P = .043), increased t-PA activity (P =
.023; Fig 1), reduced PAI activity (P = .005; Fig 2),
reduced PF 1+2 level (P = .001; Fig 3), and reduced D
dimer level (P = .005; Fig 4).
When the seven normotensive patients with acutely
symptomatic nonruptured AAA were compared with the
six normotensive patients with rupture, there was no sig-
nificant difference in platelet count, fibrinogen level, PT,
aPTT, or D dimer level. However, the differences in t-PA
activity (nonruptured: median, 1.7 IU/mL; range, 0.75
to 3.2 IU/mL; versus ruptured: median, 0.22 IU/mL;
range, 0.11 to 1.0 IU/mL; P = .01), PAI activity (non-
ruptured: median, 6.3 AU/mL; range, 3.2 to 15.4
AU/mL; versus ruptured: median, 30.3 AU/mL; range,
12.1 to 37.6 AU/mL; P = .004), and PF 1+2 level (non-
ruptured: median, 2.1 nmol/L; range, 1.1 to 5.2 nmol/L;
versus ruptured: median, 5.3 nmol/L; range, 2.5 to 6.8
nmol/L; P = .01) were maintained.
In ruptured AAA, there was no significant difference
in any of the markers between patients with hypotensive
and normotensive conditions or between patients with
Table II. Fibrinogen, platelet count, prothrombin time, and activated partial thromboplastin time in patients who
underwent operation for acutely symptomatic nonruptured and ruptured abdominal aortic aneurysm (median; range)
Assay Healthy range Ruptured AAA (n = 37) Nonruptured AAA (n = 7) P value*
Fibrinogen level 1.5 – 4.0 g/L 2.59 g/L 4.85 g/L .033
(0.46 – 6.31 g/L) (1.61 – 7.9 g/L)
Platelet count 150 – 350  109/L 178  109/L 183  109/L NS
(40 – 360  109/L) (75 – 292  109/L)
PT 10.5 – 14.5 seconds 14.3 seconds 11.8 seconds NS
(9 – 126 seconds) (10 – 100 seconds)
aPTT 28 – 40 seconds 33 seconds 29 seconds .043
(26 – 210 seconds) (26 – 36 seconds)
*P value determined with Mann-Whitney test.
AAA, Abdominal aortic aneurysm; PT, prothrombin time; aPTT, activated partial thromboplastin time.
Fig 3. Preoperative prothrombin fragment 1+2 level in acutely
symptomatic and ruptured abdominal aortic aneurysm. Upper
and lower limits of healthy range are shown with horizontal lines.
Fig 4. Preoperative D dimer level in acutely symptomatic and
ruptured abdominal aortic aneurysm. Upper and lower limits of
healthy range are shown with horizontal lines.
retroperitoneal or intraperitoneal hemorrhage. Non-
survivors had significantly lower platelet counts (nonsur-
vivors: median, 126  109/L; range, 40 to 321  109/L;
versus survivors: median, 224  109/L; range, 97 to 360
 109/L; P = .005), lower fibrinogen levels (nonsurvivors:
median, 2.03 g/L; range, 0.46 to 6.31 g/L; versus sur-
vivors: median, 2.8 g/L; range, 0.86 to 5.9 g/L; P =
.007), and prolonged aPTT (nonsurvivors: median, 39
seconds; range, 28 to 210 seconds; versus survivors:
median, 31 seconds; range, 26 to 142 seconds; P = .01) as
compared with survivors. There was no significant differ-
ence in t-PA activity, PAI activity, or PF 1+2 level between
survivors and nonsurvivors, but D dimer level was signifi-
cantly higher in nonsurvivors (P = .046).
When all patients were examined, PF 1+2 level was the
most accurate assay for distinguishing nonruptured from
ruptured AAA. With the upper limit of the healthy labo-
ratory range for PF 1+2 level as a diagnostic cut-off (>1.1
nmol/L), the test had a high sensitivity (36 of 37; 97%)
and positive predictive value (36 of 41; 88%) but low
specificity (1 of 7; 14%) and negative predictive value (1 of
2; 50%) for the diagnosis of ruptured AAA. When the cut-
off for PF 1+2 was increased to greater than or equal to
2.5 nmol/L, the test had a high sensitivity (33 of 37;
89%), specificity (6 of 7; 86%) and positive predictive value
(33 of 34; 97%), but low negative predictive value (6 of
10; 60%). When only patients with normotensive condi-
tions were examined, PAI activity was the most accurate
assay for distinguishing acutely symptomatic nonruptured
from ruptured AAA. PAI activity higher than the healthy
range (>15 AU/mL) had a high sensitivity (5 of 6; 83%)
and specificity (6 of 7; 86%) and a high positive (5 of 6;
83%) and negative predictive value (6 of 7; 86%) for the
diagnosis of rupture. When the cut-off for PAI activity was
increased to greater than or equal to 16 AU/mL, the sen-
sitivity and specificity was 5 of 6 (83%) and 7 of 7 (100%)
and the positive and negative predictive values were 5 of 5
(100%) and 7 of 8 (88%), respectively.
DISCUSSION
Hemostatic derangement is central to the thrombotic
and hemorrhagic complications that are responsible for the
considerable majority of the major morbidity and mortality
associated with aortic aneurysm surgery.7-9 Before surgery,
asymptomatic AAA is associated with increased thrombin
generation10-13 and essentially healthy systemic fibrinolytic
activity in most cases,14-16 although a proportion of cases
show increased systemic fibrinolysis.7 By contrast, hypoten-
sive patients with ruptured AAA have evidence of increased
thrombin generation and inhibition of systemic fibrinoly-
sis.7 The findings of this study corroborate the finding of a
previous report,7 provide further insight into the patho-
physiology of hemostasis associated with ruptured AAA,
and reveal novel data regarding hemostasis in patients with
acutely symptomatic nonruptured AAA.
The principal finding of this study is that acutely
symptomatic nonruptured AAA is associated with increased
primary systemic fibrinolysis, reduced secondary fibrinoly-
sis, and reduced thrombin generation as compared with
ruptured AAA. The lower t-PA activity in ruptured AAA
may be caused by increased inhibition of systemic fibrinol-
ysis (as shown with elevated PAI activity), a finding that
was not present in the patients with acutely symptomatic
nonruptured AAA. D dimer is a marker of secondary fi-
brinolysis, which occurs in response to thrombus forma-
tion and acts to restore microvascular patency. D dimer
and PF 1+2 levels were elevated in both groups of patients
but to a greater extent in the ruptured AAA group.
These differences in coagulation and fibrinolysis were
also observed when the normotensive patients with acutely
symptomatic nonruptured AAA were compared with nor-
motensive patients with rupture. No such differences were
present when normotensive and hypotensive patients with
ruptured AAA were compared. These findings suggest that
hemorrhage rather than hypotension may be one of the
principal mechanisms that triggers the generalized proco-
agulant state in patients with ruptured AAA.
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Table III. Tissue plasminogen activator activity, plasminogen activator inhibitor activity, prothrombin fragment 1+2
level, and D dimer level in patients who underwent operation for acutely symptomatic nonruptured and ruptured
abdominal aortic aneurysm (median; range)
Ruptured AAA Nonruptured AAA P
Assay Healthy range (n = 37) (n = 7) value*
t-PA activity 0.2 – 2.0 IU/mL 0.28 IU/mL 1.7 IU/mL .023
(0.06 – 9.6 IU/mL) (0.75 – 3.2 IU/mL)
PAI activity <15 AU/mL 31 AU/mL 6.3 AU/mL .005
(0.1 – 39.4 AU/mL) (3.2 – 15.4 AU/mL)
PF 1+2 level 0.4 – 1.1 nmol/L 6.4 nmol/L 2.1 nmol/L .001
(1.1 – 13.3 nmol/L) (1.1 – 5.2 nmol/L)
D dimer level 630 – 850 ng/mL 4108 ng/mL 1633 ng/mL .005
(155 – 25,947 ng/mL) (753 – 3014 ng/mL)
*P value determined with Mann-Whitney test.
AAA, Abdominal aortic aneurysm; t-PA, tissue plasminogen activator; PAI, plasminogen activator inhibitor; PF, prothrombin fragment.
The findings of this study may be explained if one con-
siders that sudden expansion or impending rupture of an
aortic aneurysm is analogous to an aortic dissection.
Fibrinolytic gene expression and focal fibrinolytic activity
have been shown within the aortic wall of patients with
asymptomatic AAA,17,18 and aortic adventitia is associated
with elevated fibrinolytic activator activity.19-21 Sudden
expansion leads to bloodflow in the marginal thrombus
adjacent to the diseased aortic wall, and as the surface area
of aortic adventitia exposed to blood flow increases, there
is increased local and systemic fibrinolysis.19 Aneurysm
rupture and subsequent hemorrhage trigger a procoagu-
lant and hypofibrinolytic state that acts to minimize local
blood loss but has the detrimental effect of stimulating
microvascular and macrovascular thrombosis.
Many clinicians have advocated the use of emergency
CT scanning to differentiate acutely symptomatic nonrup-
tured AAA from rupture. Although these early studies
reported acceptable diagnostic accuracy, the conclusions
were limited by the fact that a significant proportion of
patients did not undergo operation and thus CT scan find-
ings could not be correlated with operative findings.6
Previous results from this group have shown that, in
cases of true clinical uncertainty, CT scanning has an unac-
ceptably low sensitivity and specificity of 79% and 77%,
respectively, in patients with hemodynamically stable con-
ditions.6 There are no data to show that advances in CT
technology have been associated with improved diagnos-
tic accuracy in this clinical situation.
In this study, there was no significant difference in
platelet count, fibrinogen level, PT, aPTT, or D dimer
level between normotensive patients with nonruptured
and ruptured AAA. There were, however, significant dif-
ferences in t-PA activity, PAI activity, and PF 1+2 level.
Furthermore, preoperative PAI activity greater than or
equal to 16 AU/mL was more accurate than our experi-
ence with emergency CT scanning in these patients with
hemodynamically stable conditions. Although the mea-
surement of PAI activity may distinguish acutely sympto-
matic nonruptured AAA from ruptured AAA, currently,
the time taken to prepare the plasma and perform the
assay (approximately 2 hours) precludes its use as a diag-
nostic adjunct. The small numbers of patients studied with
nonruptured AAA do not allow the authors to reach
strong conclusions or make firm clinical recommendations.
However, should a rapid assay for PAI activity become avail-
able, then it may be of value in distinguishing rupture from
nonrupture in normotensive patients who are seen with
acutely symptomatic aneurysms.
In conclusion, these novel data show that patients
with acutely symptomatic nonruptured AAAs do not man-
ifest the same pattern of hemostatic derangement evident
in patients with rupture. Preoperative PAI activity higher
than the healthy range was more accurate than our expe-
rience with CT scanning in patients who were hemody-
namically stable with suspected ruptured AAAs.
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